| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02214106 |
| P698 | PubMed publication ID | 2525980 |
| P2093 | author name string | D K Lee | |
| D Dvornik | |||
| P2860 | cites work | Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs | Q29617192 |
| Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis | Q34484251 | ||
| Etodolac. A preliminary review of its pharmacodynamic activity and therapeutic use. | Q34562456 | ||
| Mechanisms involved in gastric mucosal resistance to injury | Q39767189 | ||
| Gastrointestinal cytoprotection by prostaglandins | Q39785702 | ||
| Mechanisms for rapid re-epithelialization of the gastric mucosal surface | Q39819636 | ||
| Gastric cytoprotection | Q39825915 | ||
| Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms | Q40108380 | ||
| Prostaglandin and protection of the gastroduodenal mucosa. | Q40244132 | ||
| A subchronic study of the effect of etodolac on the gastric mucosal prostaglandin levels in the rat. | Q41354975 | ||
| Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury | Q41682736 | ||
| Temporal relationships of the anti-inflammatory effect of etodolac in the adjuvant arthritic rat. | Q42110985 | ||
| Gastrointestinal blood loss in arthritic patients receiving chronic dosing with etodolac and piroxicam | Q43502539 | ||
| Effect of etodolac in patients with moderate renal impairment compared with normal subjects | Q43652257 | ||
| Studies on the mechanism of ethanol-induced gastric damage in rats | Q44981709 | ||
| Effect of water deprivation on aspirin disposition kinetics | Q49042012 | ||
| Prostaglandin protection of the gastric mucosa against alcohol injury--a dynamic time-related process. Role of the mucosal proliferative zone. | Q52496199 | ||
| Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. | Q52504833 | ||
| Absorption, Distribution, Metabolism, and Excretion of Naproxen in Various Laboratory Animals and Human Subjects | Q54034864 | ||
| Etodolac: effect on prostaglandin concentrations in gastric mucosa of rats | Q67280472 | ||
| Increased resistance of the rat gastric mucosa to hemorrhagic damage after exposure to an irritant. Role of the "mucoid cap" and prostaglandin synthesis | Q68090272 | ||
| Disposition and biotransformation of 14C-etodolac in man | Q69992017 | ||
| The effect of etodolac administration on renal function in patients with arthritis | Q69993119 | ||
| Etodolac compared with aspirin: an endoscopic study of the gastrointestinal tracts of normal volunteers | Q69996961 | ||
| Effects of nonsteroidal antiinflammatory drugs on renal function in patients with renal insufficiency and in cirrhotics | Q70019035 | ||
| An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastrointestinal mucosa | Q70032592 | ||
| Effect of high-dose etodolac on renal function | Q70035999 | ||
| Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa | Q70043312 | ||
| The metabolic disposition of etodolac in rats, dogs, and man | Q70568145 | ||
| Aspirin selectively inhibits prostaglandin production in human platelets | Q71062251 | ||
| Gastroscopic evaluation of anti-inflammatory agents | Q71131818 | ||
| Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins | Q71783549 | ||
| Relationship of gastric mucosal damage induced in pigs by antiinflammatory drugs to their effects on prostaglandin production | Q72040292 | ||
| Comparison in rats of the anti-inflammatory and gastric irritant effects of etodolac with several clinically effective anti-inflammatory drugs | Q72768702 | ||
| Bioavailability studies with etodolac in dogs and man | Q72809701 | ||
| Etodolac, aspirin, and gastrointestinal microbleeding | Q72812179 | ||
| Gastrointestinal Microbleeding Associated with the Use of Etodolac, Ibuprofen, Indomethacin, and Naproxen in Normal Males | Q72820139 | ||
| P304 | page(s) | 16-24 | |
| P577 | publication date | 1989-03-01 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Theoretical mechanism for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins | |
| P478 | volume | 8 Suppl 1 |
| Q67898161 | Double-blind, parallel comparison of etodolac and indomethacin in patients with osteoarthritis of the knee |
| Q68441561 | Endoscopic evaluation of etodolac and naproxen, and their relative effects on gastric and duodenal prostaglandins |
| Q38254644 | Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies |
| Q34591536 | Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states |
Search more.